GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Net Margin %

Gemina Laboratories (XCNQ:GLAB) Net Margin % : 0.00% (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Gemina Laboratories's Net Income for the three months ended in Jan. 2024 was C$-0.76 Mil. Gemina Laboratories's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil. Therefore, Gemina Laboratories's net margin for the quarter that ended in Jan. 2024 was 0.00%.

The historical rank and industry rank for Gemina Laboratories's Net Margin % or its related term are showing as below:


XCNQ:GLAB's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -151.78
* Ranked among companies with meaningful Net Margin % only.

Gemina Laboratories Net Margin % Historical Data

The historical data trend for Gemina Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Net Margin % Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Net Margin %
- - - -

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Gemina Laboratories's Net Margin %

For the Biotechnology subindustry, Gemina Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gemina Laboratories's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Net Margin % falls into.



Gemina Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Gemina Laboratories's Net Margin for the fiscal year that ended in Jan. 2024 is calculated as

Net Margin=Net Income (A: Jan. 2024 )/Revenue (A: Jan. 2024 )
=-5.217/0
= %

Gemina Laboratories's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin=Net Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-0.762/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gemina Laboratories  (XCNQ:GLAB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Gemina Laboratories Net Margin % Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gemina Laboratories (XCNQ:GLAB) Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
James Damian Tansey Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines